Advanced Biomed Inc. Common Stock (ADVB) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $6.54 (-10.66%), Market cap $0.01B, P/E ratio 1.03, 52-week low–high $0.21 ~ $7.20.
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product. The company also offers microfluidic biochips, such as A+Pre, AC-1000 CTC enrichment,
Financial statements, price targets, institutional (13F) holdings and related news for Advanced Biomed Inc. Common Stock are updated in real time on BlackAll Trade.
Advanced Biomed Inc. Common Stock trades at $6.54 (-10.66%). Real-time quotes and charts are available on BlackAll Trade.
Advanced Biomed Inc. Common Stock has a market cap of about $0.01B. Its P/E ratio is 1.03.
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan.